Nucleic acid amplification oligonucleotides and probes to Lyme disease associated Borrelia
US6074826A · kind A · utility
23Cited by
5References
111Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 1997 |
| Grant date | Jun 13, 2000 |
| Priority date | — |
| Expiry date | Oct 17, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention discloses hybridization assay probes, amplification primers, nucleic acid compositions and methods useful for detecting Borrelia nucleic acids. Hybridization assay probes and amplification primers that selectively detect Lyme disease-associated Borrelia and distinguish those Borrelia from Borrelia hermsii are disclosed. Other hybridization probes selectively detect Borrelia hermsii and not Lyme disease-associated Borrelia are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.